Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eero Mattila

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Gastroenterology|November 3, 2017
Faecal microbiota transplantation in patients with <i>Clostridium difficile</i> and significant comorbidities as well as in patients with new indications: A case seriesPerttu Lahtinen, Eero Mattila, Veli-Jukka Anttila, et al.
Frontiers in Microbiology|December 12, 2019
Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in MiceTobias L Freitag, Anna Hartikainen, Hanne Jouhten, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2020
Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndromePerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' replyPerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' replyPerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Emerging Infectious Diseases|July 21, 2021
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic SupplementsJuha Rannikko, Ville Holmberg, Matti Karppelin, et al.
Gastroenterology|December 14, 2011
Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infectionEero Mattila, Raija Uusitalo-Seppälä, Maarit Wuorela, et al.
Scandinavian Journal of Infectious Diseases|December 17, 2008
A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trialEero Mattila, Veli-Jukka Anttila, Markku Broas, et al.
Frontiers in Immunology|October 17, 2017
Unexpectedly High Prevalence of Common Variable Immunodeficiency in FinlandJannica S Selenius, Timi Martelius, Sampsa Pikkarainen, et al.
Gut|January 15, 2017
European consensus conference on faecal microbiota transplantation in clinical practiceGiovanni Cammarota, Gianluca Ianiro, Herbert Tilg, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Gastroenterology|November 3, 2017
Faecal microbiota transplantation in patients with <i>Clostridium difficile</i> and significant comorbidities as well as in patients with new indications: A case seriesPerttu Lahtinen, Eero Mattila, Veli-Jukka Anttila, et al.
Frontiers in Microbiology|December 12, 2019
Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in MiceTobias L Freitag, Anna Hartikainen, Hanne Jouhten, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2020
Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndromePerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' replyPerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' replyPerttu Lahtinen, Jonna Jalanka, Anna Hartikainen, et al.
Emerging Infectious Diseases|July 21, 2021
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic SupplementsJuha Rannikko, Ville Holmberg, Matti Karppelin, et al.
Gastroenterology|December 14, 2011
Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infectionEero Mattila, Raija Uusitalo-Seppälä, Maarit Wuorela, et al.
Scandinavian Journal of Infectious Diseases|December 17, 2008
A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trialEero Mattila, Veli-Jukka Anttila, Markku Broas, et al.
Frontiers in Immunology|October 17, 2017
Unexpectedly High Prevalence of Common Variable Immunodeficiency in FinlandJannica S Selenius, Timi Martelius, Sampsa Pikkarainen, et al.
Gut|January 15, 2017
European consensus conference on faecal microbiota transplantation in clinical practiceGiovanni Cammarota, Gianluca Ianiro, Herbert Tilg, et al.
Pageof 3